Related references
Note: Only part of the references are listed.Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Early platelet and leukocyte decline in patients with neuroinflammatory disorders after intravenous immunoglobulins
A. Totzeck et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy
Lars Hoj Markvardsen et al.
TRANSFUSION (2016)
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders
L. H. Markvardsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Share Paper
